Insulin degludec/insulin aspart (IDegAsp) treatment on glycemic control and weight in patients with insulin experienced uncontrolled type 2 diabetes mellitus: A retrospective observational study Cover

.blurhash-client-img { display: none !important; }

Insulin degludec/insulin aspart (IDegAsp) treatment on glycemic control and weight in patients with insulin experienced uncontrolled type 2 diabetes mellitus: A retrospective observational study

Endocrine Regulations

Volume 59 (2025): Issue 1 (January 2025)

By: Ramazan Cakmak, Ozge Telci Caklili, Caner Kapar, Yunus Catma, Osman Faruk Bayramlar, Fulya Calikoglu, Kubilay Karsidag and Nevin Dinccag

Open Access

|Apr 2025

Download Article

Download the full article as a PDF file.

DOI: https://doi.org/10.2478/enr-2025-0006 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 42 - 47

Published on: Apr 21, 2025

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

insulin degludec,

insulin aspart,

glycemic control,

type 2 diabetes mellitus

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2025 Ramazan Cakmak, Ozge Telci Caklili, Caner Kapar, Yunus Catma, Osman Faruk Bayramlar, Fulya Calikoglu, Kubilay Karsidag, Nevin Dinccag, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 59 (2025): Issue 1 (January 2025)Next article